Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Royalindo Investa Wijaya Tbk. (INDO) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Royalindo Investa Wijaya Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Royalindo Investa Wijaya Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Royalindo Investa Wijaya Tbk. trades at Rp169 (market cap 757.25B, 15.71M 24h volume). The key difference: Royalindo Investa Wijaya Tbk. is far larger — about 2.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Royalindo Investa Wijaya Tbk. is more actively traded (15.71M versus 963.6K). Which is the better fit depends on your goals.

DGNSINDO
Market Cap
310.75B757.25B
Volume
963.6K15.71M
Lot
9.64K157.07K
Turnover
217.67M2.65B
Average Price
225.89168.92
Value
217.67M2.65B
Indicative Equilibrium Price
226169
Indicative Equilibrium Volume
1K23

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
INDO
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Royalindo Investa Wijaya Tbk.

PT Royalindo Investa Wijaya Tbk (the Company) was established based on Notarial Deed No. 19 dated July 6, 2005 of Tse Min Suhardi, S.H., a public notary in Jakarta. The Company started its commercial operations in July 6, 2005.

Read more on INDO